Fig. 1From: Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort studyAdjusted hazard ratios of COVID-19 patients regarding 30-day survival. Intergroup imbalances were adjusted using multivariate Cox regression and different propensity score weighting approaches. The rows represent different groups/subgroup analysis of COVID-19 patientsBack to article page